Crossmark Global Holdings’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-29,494
| Closed | -$409K | – | 1326 |
|
|
2024
Q2 | $409K | Buy |
29,494
+842
| +3% | +$11.7K | 0.01% | 913 |
|
|
2024
Q1 | $450K | Buy |
28,652
+6,394
| +29% | +$100K | 0.01% | 917 |
|
|
2023
Q4 | $360K | Sell |
22,258
-103
| -0.5% | -$1.67K | 0.01% | 980 |
|
|
2023
Q3 | $285K | Buy |
22,361
+645
| +3% | +$8.22K | 0.01% | 1036 |
|
|
2023
Q2 | $375K | Sell |
21,716
-374
| -2% | -$6.46K | 0.01% | 966 |
|
|
2023
Q1 | $384K | Buy |
22,090
+1,304
| +6% | +$22.7K | 0.01% | 935 |
|
|
2022
Q4 | $192K | Sell |
20,786
-177
| -0.8% | -$1.64K | ﹤0.01% | 1205 |
|
|
2022
Q3 | $181K | Buy |
20,963
+130
| +0.6% | +$1.12K | 0.01% | 1185 |
|
|
2022
Q2 | $170K | Hold |
20,833
| – | – | ﹤0.01% | 1230 |
|
|
2022
Q1 | $254K | Buy |
20,833
+1,450
| +7% | +$17.7K | 0.01% | 1208 |
|
|
2021
Q4 | $661K | Buy |
19,383
+2,228
| +13% | +$76K | 0.01% | 787 |
|
|
2021
Q3 | $828K | Sell |
17,155
-445
| -3% | -$21.5K | 0.02% | 672 |
|
|
2021
Q2 | $795K | Sell |
17,600
-90
| -0.5% | -$4.07K | 0.02% | 688 |
|
|
2021
Q1 | $853K | Sell |
17,690
-90
| -0.5% | -$4.34K | 0.02% | 651 |
|
|
2020
Q4 | $957K | Buy |
17,780
+1,470
| +9% | +$79.1K | 0.02% | 585 |
|
|
2020
Q3 | $602K | Buy |
16,310
+100
| +0.6% | +$3.69K | 0.02% | 695 |
|
|
2020
Q2 | $502K | Buy |
16,210
+130
| +0.8% | +$4.03K | 0.01% | 751 |
|
|
2020
Q1 | $444K | Sell |
16,080
-200
| -1% | -$5.52K | 0.02% | 693 |
|
|
2019
Q4 | $476K | Sell |
16,280
-13,490
| -45% | -$394K | 0.01% | 828 |
|
|
2019
Q3 | $569K | Buy |
29,770
+120
| +0.4% | +$2.29K | 0.02% | 735 |
|
|
2019
Q2 | $651K | Sell |
29,650
-1,190
| -4% | -$26.1K | 0.02% | 693 |
|
|
2019
Q1 | $631K | Buy |
+30,840
| New | +$631K | 0.02% | 708 |
|